- Home
- NKTR vs MQT Comparison
NKTR vs MQT Comparison
Compare NKTR & MQT Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Company Overview
Basic Information| Metric | NKTR | MQT |
|---|---|---|
| Founded | 1990 | 1992 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Biotechnology: Pharmaceutical Preparations | Investment Bankers/Brokers/Service |
| Sector | Health Care | Finance |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 905.0M | 221.3M |
| IPO Year | 1994 | N/A |
Fundamental Metrics
Financial Performance| Metric | NKTR | MQT |
|---|---|---|
| Price | $44.33 | $9.90 |
| Analyst Decision | Strong Buy | |
| Analyst Count | 6 | 0 |
| Target Price | ★ $111.83 | N/A |
| AVG Volume (30 Days) | ★ 938.6K | 52.5K |
| Earning Date | 11-06-2025 | 01-01-0001 |
| Dividend Yield | N/A | ★ 4.60% |
| EPS Growth | N/A | N/A |
| EPS | N/A | ★ N/A |
| Revenue | ★ $62,600,000.00 | N/A |
| Revenue This Year | N/A | N/A |
| Revenue Next Year | N/A | N/A |
| P/E Ratio | N/A | N/A |
| Revenue Growth | N/A | ★ N/A |
| 52 Week Low | $6.48 | $8.59 |
| 52 Week High | $66.92 | $10.67 |
Technical Indicators
Market Signals| Indicator | NKTR | MQT |
|---|---|---|
| Relative Strength Index (RSI) | 38.22 | 38.48 |
| Support Level | $42.95 | $9.88 |
| Resistance Level | $47.12 | $10.05 |
| Average True Range (ATR) | 3.85 | 0.08 |
| MACD | -0.99 | -0.01 |
| Stochastic Oscillator | 11.23 | 5.00 |
Price Performance
Historical ComparisonAbout NKTR Nektar Therapeutics
Nektar Therapeutics is a clinical-stage, research-based drug discovery biopharmaceutical company focused on discovering and developing medicines in the field of immunotherapy. The company is focused on discovering and developing medicines in the field of immunotherapy. Its pipeline products are REZPEG (NKTR-358), REZPEG (NKTR-358), REZPEG (NKTR-358), NKTR-422, NKTR-0165, NKTR-255, and Others.
About MQT Blackrock MuniYield Quality Fund II Inc.
BLACKROCK MUNIYIELD QUALITY FUND II, INC. is a diversified, closed-end investment management company. Its investment objective is to provide shareholders with as high a level of current income exempt from U.S federal income taxes. The majority of its managed assets are invested in municipal bonds exempt from U.S. federal income taxes. The fund invests in municipal bonds that are in the three highest quality rating categories, or are deemed to be of comparable quality by the investment adviser at the time of investment. These are mainly long-term municipal bonds with maturities of more than ten years at the time of investment, having exposure to different sectors. The fund can also invest directly in such securities or synthetically through the use of derivatives.